Mmp9: a tough target for targeted therapy for cancer

HIGHLIGHTS

  • who: Katarzyna Augoff and colleagues from the Department Surgical Education, Wroclaw Medical University, Wroclaw, Poland have published the paper: MMP9: A Tough Target for Targeted Therapy for Cancer, in the Journal: Cancers 2022, 1847 of 23/02/2022

SUMMARY

    Remarkable upregulation of gene_expression and the activity of MMPs, especially MMP9, has been observed in various malignancies. All these mechanisms can contribute to both the activation and repression of MMP9 gene_expression. For instance, the proximal AP-1 has been found to activate MMP9 gene_expression in synergism with NF-κB and Sp1. Also the CDKN1A . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?